SciClone Pharmaceuticals (SCLN) says it's entered into an agreement with Zensun Science &...

|About: SciClone Pharmaceuticals, Inc. (SCLN)|By:, SA News Editor

SciClone Pharmaceuticals (SCLN) says it's entered into an agreement with Zensun Science & Technology granting SCLN a license and exclusive marketing and distribution rights to sell Neucardin, a treatment for intermediate to advanced chronic heart failure, in China, Hong Kong and Macau.